期刊文献+

溶液黏度对相转化水凝胶微针制备的影响 被引量:2

The Effect of Fabrication of Phase Transition Microneedles on Viscosity of Solutions Suitable
原文传递
导出
摘要 目的:选择黏度适宜的高分子溶液,制备相转化水凝胶微针。方法:通过考察两种型号的聚乙烯醇本身的黏度性质、溶液温度、几种不同性质的高分子材料,包括透明质酸、预胶化淀粉等可能影响聚乙烯醇溶液黏度的因素,使用粘度计测定其黏度值并作图比较,观察溶液黏度变化的规律。将所制溶液分别制备微针以观察针形的好坏,选择合适制备相转化水凝胶微针的溶液黏度范围。结果:实验表明黏度范围在2.5万至13万m Pa·s之间的聚合物溶液较为粘稠且流动性适宜。结论:在该黏度范围内的聚合物溶液可用以制备相转化水凝胶微针,适用于工业化生产。 Objective : The viscosity of polymer solutions to be casted into specific molds for the fabrication of phase-transition microneedles was investigated. Methods: The instinct viscosity properties of two types of polyvinyl alcohol(PVA) were investigated.The other factors including the temperature of solutions, the existence of different polymers, such as hyaluronic acid(HA), and pregelatine starch(PCS), were also studied. The viscosity values were measured with viscometer and curved to conclude the rule of viscosity change. The solutions were also used to fabricate microneedles to observe the appearance of needles to choose the suitable viscosity scope. Results: The experiences showed that the solution whose viscosity was within the scope of 25,000 to 130,000 m Pa·s was with proper mobility. Conclusions: The solutions with the above mentioned viscosity was suitable for the manufacturing of good shape microneedles in commercial processes.
出处 《现代生物医学进展》 CAS 2014年第36期7007-7010,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81373366)
关键词 黏度 相转化水凝胶微针 聚乙烯醇 Viscosity Phase transition microneedles Polyvinyl alcohol
  • 相关文献

参考文献21

  • 1Yang D,Li Y,Nie J.Preparation of gelatin/PVA nanofibers and their potential application in controlled release of drugs[J].CarbohydPolym,2007,69(3):538-543.
  • 2Prausnitz MR,Langer R.Transdermal drug delivery[J],Nat Biotechnol,2008,26(11):1261-1268.
  • 3More S,Ghadge T,Dhole S.Microneedle:an Advanced Technique in Transdermal Drug Delivery System[J].Asian J.Res.Pharm.Sci,2013 ,3(3):141-148.
  • 4Nayak A,Das D B.Potential of biodegradable microneedles as a trans- dermal delivery vehicle for lidocaine[J].Biotechnol Lett,2013:1-13.
  • 5Pearton M,Sailer V,Coulman SA,et al.Microneedle delivery of plasmid DNA to living human skin:Formulation coating,skin inser- tion and gene expression[J].J Control Release,2012,160(3):561-569.
  • 6Pattani A,McKay PF,Garland MJ,et al.MicToneedle mediated intradermal delivery of adjuvanted recombinant HIV-I CN54gpl40 effectively primes mucosal boost inoculations[J],J Control Release,2012,162(3):529-537.
  • 7Barouch DH.Polymer multilayer tattooing for enhanced DNA vaccination[J].Tissue Eng,2013,4(12):367-376.
  • 8Chandrasekhar S,Iyer LK,Panchal JP,et al.Microarrays and microneedle arrays for delivery of peptides,proteins,vaccines and other applications[J].Expert Opin Drug Deliv,2013,10(8):1-16.
  • 9El-Laboudi A,Oliver N S,Cass A,et al.Use of Microneedle Array Devices for Continuous Glucose Monitoring:A Review[J].Diabetes Technol The,2013,15(1):101-115.
  • 10Wu F,Yang S,Yuan W,et al.Challenges and strategies in develo- ping microneedle patches for transdermal delivery of protein and peptide therapeutics[J].Curr Pharm Biotechno,2012,13(7):1292-1298.

同被引文献20

  • 1Prausnitz M R, R Langer. Transdermal Drug Delivery [J], Nature Biotechnology, 2008, 26(11): 1261-1268.
  • 2Tanner T, Marks R. Delivering Drugs by the Transdermal Route: Review and Comment [J]. Skin Research And Technology, 2008, 14 (3): 249-260.
  • 3Sivamani R K, Liepmann D, Maibach H I. Microneedles and Transdermal Applications [J]. Expert Opinion on Drug Delivery, 2007, 4(1): 19-25.
  • 4Li Wei-ze, Huo Mei-rong, Zhou Jian-ping, et al. Super-Short Solid Silicon Microneedles for Transdermal Drug Delivery Applications[J]. International Journal of Pharmaceutics, 2010, 389(1): 122-129.
  • 5Donnelly R F, Desmond I J Morrow, Thakur R R Singh, et al. Processing Difficulties and Instability of Carbohydrate Microneedle Arrays[J]. Drug Development and Industrial Pharmacy, 2009, 35(10): 1242-1254.
  • 6Nandagopal M S Giri, Antony R, Rangabhashiyam S, et al. Overview of Microneedle System: a Third Generation Transdermal Drug Delivery Approach [J]. Microsystem Technologies, 2014, 20 (7):1249-1272.
  • 7Verhoeven M, Bystrova S, Wirmubst L, et al. Applying Ceramic Nanoporous Microneedle Arrays as a Transport Interface in Egg Plants and an Ex-Vivo Human Skin Model [J]. Microelectronic Engineering, 2012, 98:659-662.
  • 8Lee J W, Park J H, Prausnitz M R. Dissolving Mieroneedles for Transdermal Drug Delivery [J]. Biomaterials, 2008, 29 (13): 2113-2124.
  • 9Guo L, Man P, Gao Y, et al. Dissolving Microneedle Arrays for Intradermal Immunization of Hepatitis B Virus DNA Vaccine [J]. Procedia in Vaceinology, 2015, 9:24-30.
  • 10Wu F, Yang S, Yuan W, et al. Challenges and Strategies in Developing Microneedle Patches for Transdermal Delivery of Protein and Peptide Therapeutics [J].Current Pharmaceutical Biotechnology, 2012, 13(7): 1292-1298.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部